Anúncio
Anúncio
TNDM
Tandem Diabetes Care, Inc.
21.55
USDPatrocinado
-0.43
-1.94%
02 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
21.59
+0.04
+0.16%
Relatórios de Lucros TNDM
Rácio de surpresa positiva
TNDM separação 20 de 40 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$282.30M
/-$0.09
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+13.26%
/-70.97%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-0.12%
/-1000.00%
Tandem Diabetes Care, Inc. earnings per share and revenue
On 06 de nov. de 2025, TNDM reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 3.19% surprise. Revenue reached 249.25 milhão, compared to an expected 241.70 milhão, with a 3.12% difference. The market reacted with a +21.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 analistas forecast an EPS of -0.09 USD, with revenue projected to reach 282.30 milhão USD, implying an diminuir of -70.97% EPS, and aumentar of 13.26% in Revenue from the last quarter.
FAQ
What were Tandem Diabetes Care, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Tandem Diabetes Care, Inc. reported EPS of -$0.31, beating estimates by 3.19%, and revenue of $249.25M, 3.12% above expectations.
How did the market react to Tandem Diabetes Care, Inc.'s Q3 2025 earnings?
The stock price moved up 21.98%, changed from $13.33 before the earnings release to $16.26 the day after.
When is Tandem Diabetes Care, Inc. expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Tandem Diabetes Care, Inc.'s next earnings report?
Based on 25
analistas, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.09 and revenue of $282.30M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio